Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset-Reference-Cited by-同舟云学术

Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset

Published:2023-01 Issue: Volume:939 Page:175429
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Frouni Imane^ORCID,Kwan Cynthia^ORCID,Belliveau Sébastien^ORCID,Hamadjida Adjia,Bédard Dominique,Nuara Stephen G.,Gourdon Jim C.,Huot Philippe^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Diagnosis and treatment of Parkinson disease: a review;Armstrong;JAMA,2020

2. The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results;Beaudry;J. Neural. Transm.,2020

3. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata;Bradley;J. Neurosci.,2000

4. mGlu4 allosteric modulation for treating Parkinson's disease;Charvin;Neuropharmacology,2018

5. Pharmacological treatment of Parkinson disease: a review;Connolly;JAMA,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the mGlu₂ positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset;European Journal of Neuroscience;2024-06-27

2. Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-20

3. Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-11

4. Targeting metabotropic glutamate receptors for the treatment of Parkinson’s disease;Neurodegenerative Disease Management;2023-08

5. Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease;Neural Regeneration Research;2023-07-28